GlassScriptPhysician profile
John S Dennis
NPI 1871584060
$393.18
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2020: $11.25 · 2021: $11.09 · 2022: $17.95 · 2023: $23.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $23.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $133.79 | 2019 | |
| Genzyme Corporation | $35.75 | 2019 | |
| Stryker Corporation | $33.99 | 2019 | |
| Ge Healthcare | $23.49 | 2023 | |
| Smith+Nephew, INC. | $22.34 | 2020-2021 | |
| Janssen Biotech, INC. | $20.49 | 2019 | |
| Terumo Medical Corporation | $20.47 | 2019 | |
| Medtronic USA, INC. | $18.42 | 2019 | |
| Siemens Medical Solutions USA, INC. | $17.95 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.36 | 2019 | |
| Seagen INC. | $14.25 | 2019 | |
| Teleflex LLC | $13.89 | 2019 | |
| Sirtex Medical INC | $11.26 | 2019 | |
| Cardiovascular Systems INC. | $10.73 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Dennis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.